Correlation of serum leptin and resistin levels with the metabolic risk factors of pre- and postmenopausal women in South India

BioMedicine (Netherlands)

Volumn 3, Issue 4, 2013, Pages 167-173

  Priya, Tanu ^a   Chowdhury, Minakshi G ^a   Vasanth, Karunamoorthy ^a   Vijayakumar, Thangavel Mahalingam ^a   Ilango, Kaliappan ^a   Agrawal, Aruna ^b   Dubey, Govind Prasad ^b  

^a SRM INSTITUTE OF SCIENCE AND TECHNOLOGY   (India)

^b BANARAS HINDU UNIVERSITY   (India)

Author keywords

Leptin; Lipid profile; Menopause; Metabolic syndrome; Obesity; Resistin

Indexed keywords

GLUCOSE; LEPTIN; RESISTIN; TRIACYLGLYCEROL;

ADULT; AGED; ANTHROPOMETRY; ARTICLE; BLOOD PRESSURE MEASUREMENT; BODY MASS; CONTROLLED STUDY; CORRELATION ANALYSIS; CROSS-SECTIONAL STUDY; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; INDIA; LIPID BLOOD LEVEL; MENSTRUATION; METABOLIC RISK FACTOR; POSTMENOPAUSE; PREMENOPAUSE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RISK FACTOR; RURAL POPULATION; SYSTOLIC BLOOD PRESSURE;

EID: 84888884000     PISSN: 22118020     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biomed.2013.05.002     Document Type: Article

References (29)

1. Wong N.D. Review: cardiovascular risk assessment in the metabolic syndrome, screening for subclinical disease, and implications for treatment. Br J Diabetes Vasc Dis 2005, 5:305-314.
2. Kanbak G., Akalinb A., Dokumacioglua A., Ozcelika E., Balc C. Cardiovascular risk assessment in patients with type 2 diabetes mellitus and metabolic syndrome: role of biomarkers. Diabetes Metab Syndr 2011, 5:7-11.
3. Carr C.M. The emergence of the metabolic syndrome with menopause. J Clin Endocrinol Metab 2003, 88:2404-2411.
4. Lin W.Y., Yang W.S., Lee L.T., Chen C.Y., Liu C.S., Lin C.C., et al. Insulin resistance, obesity, and metabolic syndrome among non-diabetic pre- and post-menopausal women in North Taiwan. Int J Obes 2006, 30:912-917.
5. Fernandez-Alonso A.M., Cuadros J.L., Chedraui P., Mendoza M., Cuadros A.M., Perez Lopez F.R. Obesity is related to increased menopausal symptoms among Spanish women. Menopause Int 2010, 16:105-110.
6. Lovejoy J.C. The menopause and obesity. Prim Care 2003, 30:317-325.
7. Khaw K.T. Epidemiology of the menopause. Br Med Bull 1992, 48:249-261.
8. Singh A., Arora A.K. Profile of menopausal women in rural north India. Climacteric 2005, 8:177-184.
9. Stanford J.L., Hartge P., Brinton L.A., Hoover R.N., Brookmeyer R. Factors influencing the age at natural menopause. J Chronic Dis 1987, 40:995-1002.
10. Dzau V.J. Markers of malign cross the cardiovascular continuum. Interpretation and application. Circulation 2004, 109:IV1-IV2.
11. Singh B., Arora S., Goswami B., Mallika V. Metabolic syndrome: A review of emerging markers and management. Diabetes Metab Syndr 2009, 3:240-254.
12. Tommaselli G.A., Di Carlo C., Pellicano M., Nasti A., Ferrara C., DiSpiezio Sardo A., et al. Changes of leptin levels in menopause. Minerva Ginecol 2001, 53:193-198.
13. Rosenbaum M., Nicolson M., Hirsch J., Heymsfield S.B., Gallagher D., Chu F., et al. Effects of gender, body composition, and menopause on plasma concentrations of leptin. J Clin Endocrinol Metab 1996, 81:3424-3427.
14. Sharma R., Kumar C., Gangwani S., Sugga G.S., Rana A.C. Resistin and cardiovascular disorder. Afr J Pharm Pharmacol 2011, 5:1-5.
15. Cooke J.P., Oka R.K. Does leptin cause vascular disease. Circulation 2002, 106:1904-1905.
16. Van Dielen F.M., van't Veer C., Schols A.M., Soeters P.B., Buurman W.A., Greve J.W. Increased leptin concentrations correlate with increased concentrations of inflammatory markers in morbidly obese individuals. Int J Obes Relat Metab Disord 2001, 25:1759-1766.
17. Prasad D.S., Kabir Z., Dash A.K., Das B.C. Abdominal obesity, an independent cardiovascular risk factor in Indian subcontinent: a clinico epidemiological evidence summary. JCardiovasc Dis Res 2011, 2:199-205.
18. Hitman G.A., McCarthy M.I., Mohan V., Viswanathan M. The genetics of non-insulin dependent diabetes mellitus in South India. An overview. Ann Med 1992, 24:491-497.
19. Moller N., O'Brien P., Nair K.S. Disruption of the relationship between fat content and leptin levels with aging in humans. JClin Endocrinol Metab 1998, 83:931-934.
20. Shimizu H., Shimomura Y., Nakanishi Y., Futawatari T., Ohtani K., Sato N., et al. Estrogen increases invivo leptin production in rats and human subjects. J Endocrinol 1997, 154:285-292.
21. Nishat A., Sohail R.K., Fauzia S. Leptin levels in pre and post-menopausal Pakistani Women. J Pak Med Assoc 2006, 56:3-5.
22. Douchi T., Iwamoto I., Yoshimitsu N., Kosha S., Nagata Y. Leptin production in pre and postmenopausal women. Maturitas 2002, 42:219-223.
23. Pantsulaia I., Livshits G., Trofimov S., Kobyliansky E. Genetic and environmental determinants of circulating resistin level in a community-based sample. Eur J Endocrinol 2007, 156:129-135.
24. Oguz S., Aytan H., Tapisiz O.L., Gunyeli I., Erdem S., Tuncay G., et al. Is leptin associated with serum lipid profile or any other parameters of blood biochemistry in post-menopausal women with osteoporosis?. J Int Med Res 2004, 32:359-366.
25. Azuma K., Katsukawa F., Oguchi S., Murata M., Yamazaki H., Shimada A., et al. Correlation between serum resistin level and adiposity in obese individuals. Obes Res 2003, 11:997-1001.
26. Casiglia E., d'Este D., Ginocchio G., Colangeli G., Onesto C., Tramontin P., et al. Lack of influence of menopause on blood pressure and cardiovascular risk profile: a 16-year longitudinal study concerning a cohort of 568 women. JHypertens 1996, 14:729-736.
27. Rossi R., Nuzzo A., Origliani G., Modena M.G. Metabolic syndrome affects cardiovascular risk profile and response to treatment in hypertensive postmenopausal women. Hypertension 2008, 52:865-875.
28. Bengtsson C., Lindquist O. Menopausal effects on risk factors for ischaemic heart disease. Maturitas 1979, 3:165-170.
29. Meade T.W., Haines A.P., Imeson J.D. Menopausal status and haemostatic variables. Lancet 1983, 8314:22-24.